Differential effects of lidocaine and mexiletine on relaxations to ATP- sensitive K+ channel openers in rat aortas

Anesthesiology

Volumn 90, Issue 4, 1999, Pages 1165-1170

  Kinoshita, Hiroyuki ^a   Ishikawa, Toshizo ^b   Hatano, Yoshio ^c  

^a JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiarrhythmic drugs; Glibenclamide; Ion channels; Local anesthetics; Vasodilation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CROMAKALIM; DILTIAZEM; GLIBENCLAMIDE; LIDOCAINE; MEXILETINE; PHENYLEPHRINE; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM ION;

ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTERY DILATATION; ARTICLE; CHANNEL GATING; COMPARATIVE STUDY; CONCENTRATION RESPONSE; DRUG EFFECT; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; AORTA; CROMAKALIM; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; LIDOCAINE; MALE; MEXILETINE; POTASSIUM CHANNELS; RATS; RATS, INBRED WKY; VASODILATION;

EID: 0032902457     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199904000-00032     Document Type: Article

References (32)

1. Quayle JM, Nelson MT, Standen NB: ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 1997; 77:1165-232
2. Cook NS: The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci 1988; 9:21-8
3. + channels in Xenopus oocytes. Eur J Pharmacol 1993; 247:267-72
4. Olschewski A, Brau ME, Olschewski H, Hempelmann G, Vogel W: ATP-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine: Possible impact on the antiarrhythmic action of lidocaine. Circulation 1996; 93:656-9
5. + channels. Br J Pharmacol 1995; 115:381-2
6. Kinoshita H, Katusic ZS: Role of potassium channels in relaxations of isolated canine basilar arteries to acidosis. Stroke 1997; 28: 433-8
7. + channel openers. J Vasc Res 1993; 30:2-12
8. McPherson GA, Angus JA: Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. Br J Pharmacol 1990; 100:201-6
9. Ksoll E, Parsons AA, Maekert JRL, Schilling L, Wahl M: Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery. Naunyn Schmiedebergs Arch Pharmacol 1991; 343:377-83
10. 86Rb efflux in canine arterial smooth muscle. Br J Pharmacol 1991; 103:1033-40
11. Kuriyama H, Kitamura K, Nabata H: Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol Rev 1995; 47:387-573
12. Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995; 268:C799-822
13. + channels in human coronary artery vascular smooth muscle cells. Am J Physiol 1997; 273:C161-71
14. Josephson IR: Lidocaine blocks Na, Ca and K currents of chick ventricular myocytes. J Mol Cell Cardiol 1988; 20:593-604
15. Brau ME, Nau C, Hempelmann G, Vogel W: Local anesthetics potently block a potential insensitive potassium channel in myelinated nerve. J Gen Physiol 1995; 105:485-505
16. Yang Q, Padrini R, Bova S, Piovan D, Magnolfi G: Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart. Br J Pharmacol 1995; 114:1745-9
17. Mitcheson JS, Hancox JC: Modulation by mexiletine of action potentials, L-type Ca current and delayed rectifier K current recorded from isolated rabbit atrioventricular nodal myocytes. Pflugers Arch 1997; 434:855-8
18. Woosley RL, Funck-Brentano C: Overview of the clinical pharmacology of antiarrhythmic drugs. Am J Cardiol 1988; 61:61A-9A
19. Nelson LS, Hoffman RS: Mexiletine overdose producing status epilepticus without cardiovascular abnormalities. J Toxicol Clin Toxicol 1994; 32:731-6
20. Dohi Y, Kojima M, Sato K: Vasorelaxant effect of mexiletine in mesenteric resistance arteries of rats. Br J Pharmacol 1994; 111:673-80
21. Johns RA, DiFazio CA, Longnecker DE: Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. ANESTHESIOLOGY 1985; 62:141-4
22. Evans GRD, Gherardini G, Gurlek A, Langstein H, Joly GA, Cromeens DM, Sukumaran AV, Williams J, Kilbourn RG, Wang B-G, Lundeberg T: Drug-induced vasodilation in an in vitro and in vivo study: The effects of nicardipine, papaverine, and lidocaine on the rabbit carotid artery. Plast Reconstr Surg 1997; 100:1475-81
23. Winkle RA, Glantz SA, Harrison DC: Pharmacologic therapy of ventricular arrhythmias. Am J Cardiol 1975; 36:629-50
24. Gottlieb SS, Weinberg M: Comparative hemodynamic effects of mexiletine and quinidine in patients with severe left ventricular dysfunction. Am Heart J 1991; 122:1368-74
25. Frinz KW, Lullwitz E, Scheld H, Kirchner E: Haemodynamic effects of mexiletine and lidocaine in coronary surgery patients [in German with abstract in English]. Anasthesiol Intensivther Notfallmed 1983; 18:125-8
26. Estes NAM III, Manolis AS, Greenblatt DJ, Garan HG, Ruskin JN: Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion. Am Heart J 1989; 117:1060-4
27. Talbot RG, Clark RA, Nimmo J, Neilson JMM, Julian DG, Prescott LF: Treatment of ventricular arrhythmias with mexiletine. Lancet 1973; II:399-404
28. Xuecheng J, Xiaobin W, Bo G, Wen Z, Ningli H, Yucai Z, Depeng X, Yongzhong X: The plasma concentrations of lidocaine after slow versus rapid administration of an initial close of epidural anesthesia. Anesth Analg 1997; 84:570-3
29. Edvardsson N, Olsson SB: Clinical value of plasma concentrations of antiarrhythmic drugs. Eur Heart J 1987; 8:83-9
30. + channels mediate dilatation of cerebral arterioles during hypoxia. Circ Res 1994; 74:1005-8
31. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A 1995; 92:4666-70
32. Kwan AL, Lin CL, Yanamoto H, Howng SL, Kassell NF, Lee KS: Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 1998; 42:347-50